Minocycline may attenuate postherpetic neuralgia

Medical Hypotheses

Volumn 73, Issue 5, 2009, Pages 744-745

  Zhang, Qiang ^a   Peng, Liping ^a   Zhang, Deren ^a  

^a The 6th Affiliated Hospital of Shenzhen University Health Science Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; GLYCOPROTEIN GP 120; KETAMINE; MINOCYCLINE; OPIATE DERIVATIVE; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLERGIC ENCEPHALOMYELITIS; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; CELL METABOLISM; CHRONIC PAIN; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; ELECTROSTIMULATION THERAPY; GLIA CELL; HERPES ZOSTER; HUMAN; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE BLOCK; NERVE CELL STIMULATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; TRANSCUTANEOUS NERVE STIMULATION; VARICELLA ZOSTER VIRUS;

HUMANS; MINOCYCLINE; NEURALGIA, POSTHERPETIC;

ANIMALIA; HERPES ZOSTER; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70349729939     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.04.028     Document Type: Article

References (36)

1. Wood M.J. Herpes zoster and pain. Scand J Infect Suppl 78 (1991) 53-61
2. Rowbotham M.C. Postherpetic neuralgia. Semin Neurol 14 (1994) 247-254
3. Dworkin R.H., and Portenoy R.K. Pain and its persistence in herpes zoster. Pain 67 (1996) 241-251
4. Haanpaa M., Dastidar P., Weinberg A., et al. CSF and MRI findings in patients with acute herpes zoster. Neurology 51 (1998) 1405-1411
5. Ku C.C., Zerboni L., Ito H., Graham B.S., Wallace M., and Arvin A.M. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med 200 (2004) 917-925
6. Torigo S., Ihara T., and Kamiya H. IL-12, IFN-gamma, and TNF alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella. Microbiol Immunol 44 (2000) 1027-1031
7. Kikuchi A., Kotani N., Sato T., Takamura K., Sakai I., and Matsuki A. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 24 (1999) 287-293
8. Kotani N., Kushikata T., Hashimoto H., et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 343 (2000) 1514-1519
9. Watson C.P.N., Deck J.H., Morshead C., Van der Kooy D., and Evans R.J. Postherpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 44 (1991) 105-117
10. Owolabi S.A., and Saab C.Y. Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal horn. FEBS Lett 580 (2006) 4306-4310
11. Zhuang Z.-Y., Gerner P., Woolf C.J., and Ji R.-R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to the mechanical allodynia in this neuropathic pain model. Pain 114 (2005) 149-159
12. Zhuang Z.-Y., Wen Y.-R., Zhang D.R., Borsello T., et al. A peptide c-jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 26 (2006) 3551-3560
13. Minghetti L., and Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 54 (1998) 99-125
14. Eriksson N.P., Persson J.K., Svensson M., Arvidsson J., Molander C., and Aldskogius H. A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat. Exp Brain Res 96 (1993) 19-27
15. Raghavendra V., Tanga F.Y., and DeLeo J.A. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 29 (2004) 327-334
16. Wagner R., DeLeo J.A., Heckman H.M., and Myers R.R. Peripheral nerve pathology following sciatic cryoneurolysis: relationship to neuropathic behaviors in the rat. Exp Neurol 133 (1995) 256-264
17. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2 (2003) 973-985
18. Clark A.K., Yip P.K., Grist J., et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci 104 (2007) 10655-10660
19. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci 24 (2001) 450-455
20. Ledeboer A., Liu T., Shumilla J.A., et al. The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. Neuron Glia Biol 1 (2007) 1-13
21. Mika J., Osikowicz M., Mkuch W., and Przewlocka B. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol 560 (2007) 142-149
22. Wells J.E., Hurlbert R.J., Fehlings M.G., and Yong V.W. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126 (2003) 1628-1637
23. Teng Y.D., Choi H., Onario R.C., et al. Minocycline inhibits contusiontriggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci USA 101 (2004) 3071-3076
24. Xu L., Fagan S.C., Waller J.L., et al. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol 4 (2004) 7
25. Tikka T.M., and Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166 (2001) 7527-7533
26. Baptiste D.C., Hartwick A.T., Jollimore C.A., Baldridge W.H., Seigel G.M., and Kelly M.E. An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death. Mol Pharmacol 66 (2004) 1113-1122
27. Baptiste D.C., Powell K.J., Jollimore C.A., et al. Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience 134 (2005) 575-582
28. Dommergues M.A., Plaisant F., Verney C., and Gressens P. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 121 (2003) 619-628
29. Zhu S., Stavrovskaya I.G., Drozda M., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78
30. Cho K.O., La H.O., Cho Y.J., Sung K.W., and Kim S.Y. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J Neurosci Res 83 (2006) 285-291
31. Brundula V., Rewcastle N.B., Metz L.M., Bernard C.C., and Yong V.W. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125 (2002) 1297-1308
32. Ledeboer A., Sloane E.M., Milligan E.D., et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115 (2005) 71-83
33. Popovic N., Schubart A., Goetz B.D., Zhang S.C., Linington C., and Duncan I.D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 51 (2002) 215-223
34. Smith G.A., Tsui H.W., Newell E.W., et al. Functional up-regulation of HERG K+channels in neoplastic hematopoietic cells. J Biol Chem 277 (2002) 18528-18534
35. Wang A.L., Yu A.C., Lau L.T., et al. Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int 47 (2005) 152-158
36. Plaghki L., Adriaensen H., Morlion B., Lossignol D., and Devulder J. Systematic overview of the pharmacological management of postherpetic neuralgia: an evaluation of the clinical value of critically selected drug treatments based on efficacy and safety outcomes from randomized controlled studies. Dermatology 208 (2004) 206-216